Calidi Biotherapeutics Q4 2025 Earnings Narrowed Loss Surprises Stock Declines GNK Q1 2026 Earnings Massive EPS Beat Driven by Strong Market Conditions IFRX Q4 2025 Earnings NarrowerThanExpected Loss Supports Stock Rally FHN Q1 2026 Earnings EPS Beats Estimates by 623 as Stock Edges Higher PACB Q1 2026 Earnings Narrowerthanexpected loss drives positive market reaction BCDA Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Advances Pipeline